HSBC Holdings’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-3,379
Closed -$385K 2892
2022
Q4
$385K Sell
3,379
-1,771
-34% -$206K ﹤0.01% 2402
2022
Q3
$566K Buy
+5,150
New +$738K ﹤0.01% 2110
2022
Q1
Sell
-3,649
Closed -$755K 3398
2021
Q4
$755K Buy
3,649
+1,661
+84% +$343K ﹤0.01% 2207
2021
Q3
$387K Buy
1,988
+351
+21% +$86.3K ﹤0.01% 2407
2021
Q2
$463K Buy
+1,637
New +$444K ﹤0.01% 2237
2021
Q1
Sell
-1,495
Closed -$291K 2977
2020
Q4
$291K Buy
+1,495
New +$264K ﹤0.01% 2585
2020
Q3
Sell
-2,508
Closed -$348K 2800
2020
Q2
$348K Sell
2,508
-1,859
-43% -$171K ﹤0.01% 2046
2020
Q1
$268K Buy
+4,367
New +$398K ﹤0.01% 2114
2019
Q4
Sell
-8,546
Closed -$886K 3138
2019
Q3
$886K Buy
+8,546
New +$919K ﹤0.01% 2007
2019
Q2
Sell
-6,798
Closed -$867K 2790
2019
Q1
$867K Buy
6,798
+496
+8% +$62.9K ﹤0.01% 1885
2018
Q4
$788K Sell
6,302
-4,860
-44% -$831K ﹤0.01% 1914
2018
Q3
$2.47M Buy
+11,162
New +$2.26M ﹤0.01% 1397

Other funds holding MED

HSBC Holdings's MED Position: Q1 2023 in Review

HSBC Holdings sold out of Medifast (MED) in Q1 2023, closing a stake of 3,379 shares — an estimated $385K sold.

HSBC Holdings first reported a position in MED in Q3 2018 and held it in 12 quarters. The position peaked at $2.47M in Q3 2018. 267 funds tracked by Wall St. Rank hold MED as of Q1 2023.

  • HSBC Holdings reported no remaining Medifast position as of Q1 2023 after selling out during the quarter.
  • HSBC Holdings sold 3,379 Medifast shares in Q1 2023, an estimated $385K.
  • HSBC Holdings first reported a position in Medifast in Q3 2018 and held it in 12 quarters.
  • HSBC Holdings's Medifast position peaked at $2.47M in Q3 2018.
  • 267 funds tracked by Wall St. Rank held Medifast as of Q1 2023.

Based on HSBC Holdings's 13F filing for Q1 2023, filed 15 May 2023.